Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890357 · ClinicalTrials.gov registry record
Identifying Factors Underlying the Discontinuation of Triptans
A clinical trial of Migraine and Medication Adherence, sponsored by Mayo Clinic.
- Completed
- Registry status
- 292
- Enrollment target
- 3
- Study locations
NCT00890357 is a study of Migraine and Medication Adherence that has completed, run by Mayo Clinic. The registered enrollment target is 292 participants, below the 355-participant average among 102 other Migraine trials with a reported enrollment target (18% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00890357, a study of Migraine and Medication Adherence, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 292 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.
Conditions Studied
Study Locations (3)
Florida
- University of South Florida College of Medicine - Tampa
Missouri
- Washington University School of Medicine - St Louis
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00890357
The ClinicalTrials.gov registry entry for NCT00890357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 355-participant average among 102 other Migraine trials with a reported enrollment target (18% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 0 interventions.
NCT00890357 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT00890357 about?
NCT00890357 is a clinical study titled "Identifying Factors Underlying the Discontinuation of Triptans". The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.
What is the current status of trial NCT00890357?
This trial is currently completed. The enrollment target is 292 participants. The study started on 2009-08. Estimated completion is 2012-06.
What conditions does trial NCT00890357 study?
This clinical trial studies the following conditions: Migraine, Medication Adherence.
Who is sponsoring clinical trial NCT00890357?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00890357 being conducted?
This trial has 3 study locations across Florida, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Migraine Manager (R01)
RECRUITING · Phase 2
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
RECRUITING
-
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
RECRUITING · Phase 3
-
Mechanistic Studies of Psilocybin in Headache Disorders
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.